MTDH and breast carcinoma: Metadherin (MTDH) is an oncogene thought to affect many cancer related pathways such as PI3K/AKT and Wnt, and its downregulation was shown to increase the chemosensitivity of many tumours such as prostate and breast cancer to 5-fluorouracil (5-FU), paclitaxel and doxorubicin; the exact mechanism though had remained unknown.